Cambridge PhD Training Programme in Chemical Biology and Molecular Medicine

The aim of this 4-year PhD programme (formerly the CRUK PhD Training Programme in Medicinal Chemistry) is to train the next generation of synthesis chemists to PhD level who will be experienced in working at the interface between synthetic chemistry and biology at various stages of pre-clinical drug discovery. Our interdisciplinary programme brings together world-class research groups with facilities in synthesis chemistry, pharmacology, biochemistry and biology. PhD applicants are expected to hold a first class Masters degree in Chemistry.

During the first year students embark on their practical chemistry training and are brought up to speed in disease-focussed research by a combination laboratory rotations in chemistry and biology (academic and industrial), workshops and hot topics. The transition to second year is marked by students developing their own PhD proposals in conjunction with chemistry and biology supervisors involved with the programme. Projects are often inspired and driven by individual interests and student interactions during the first year.

This year's 5th Programme Symposium was held at the CRUK CRI on Monday 10th October 2011. The photographs are from the 2011 (above) symposium with Dr Tom Heightman (Head of Medicinal Chemistry at Astex) and the 2010 (below) symposium with Dr Tony Wood (Worldwide Head of Medicinal Chemistry for Pfizer).


 

The programme is funded by Cancer Research UK. Funding for new studentships starting in October 2012 will be from the Cambridge Cancer Centre, The Department of Chemistry and the School of Physical Sciences (University of Cambridge). We also interact with local pharmaceutical and biotech companies (Cancer Research Technology, BioFocus, Domainex and Astex Therapeutics) for a broad range of activities such as workshops and lab rotations in Year 1.